We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

98 hedge funds and large institutions have $115M invested in VanEck Biotech ETF in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.61% less ownership

Funds ownership: 35.45% → 34.84% (-0.61%)

6% less funds holding

Funds holding: 104 → 98 (-6)

11% less capital invested

Capital invested by funds: $130M → $115M (-$14.3M)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

57% less call options, than puts

Call options by funds: $276K | Put options by funds: $644K

Holders
98
Holders Change
-6
Holders Change %
-5.77%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
25
Closed
16
Calls
$276K
Puts
$644K
Net Calls
-$368K
Net Calls Change
-$2.77M

Top Buyers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
+$7.19M
2
BFG
Bleakley Financial Group
New Jersey
+$2.83M
3
Bank of America
Bank of America
North Carolina
+$1.18M
4
Citadel Advisors
Citadel Advisors
Florida
+$840K
5
Citigroup
Citigroup
New York
+$816K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.8M
2
Wells Fargo
Wells Fargo
California
-$5.13M
3
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$3.11M
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$2.66M
5
MIM
Miller Investment Management
Pennsylvania
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
CT
76
Coastline Trust
Rhode Island
$29.1K – – –
CA
77
CoreCap Advisors
Michigan
$29.1K – – –
AIM
78
Anchor Investment Management
South Carolina
$24.5K – – –
US Bancorp
79
US Bancorp
Minnesota
$22.7K – – –
GRP
80
Global Retirement Partners
California
$19K +$18.5K +124 New
FFA
81
Farther Finance Advisors
California
$18.5K – – –
AF
82
Allworth Financial
California
$18.4K – – –
FCMT
83
Founders Capital Management (Texas)
Texas
$15.3K – – –
WT
84
Whittier Trust
California
$15.3K – – –
FP
85
Financial Perspectives
Minnesota
$13.5K – – –
HWM
86
HighMark Wealth Management
Minnesota
$12.3K – – –
1NWS
87
1 North Wealth Services
Maryland
$12K – – –
PS
88
Principal Securities
Iowa
$11K – – –
HCM
89
Hollencrest Capital Management
California
$10.7K – – –
BlackRock
90
BlackRock
New York
$10.7K +$10.4K +70 New
LFG
91
Larson Financial Group
Missouri
$10.7K +$10.4K +70 New
BTI
92
Blue Trust Inc
Georgia
$6.59K +$6.4K +43 New
NA
93
NewEdge Advisors
Louisiana
$5.92K – – –
CPA
94
Cardiff Park Advisors
California
$5.37K – – –
AIP
95
Ameritas Investment Partners
Nebraska
$4.6K – – –
National Bank of Canada
96
National Bank of Canada
Quebec, Canada
$3.83K – – –
PP
97
Pacifica Partners
Canada
$3.82K – – –
Qube Research & Technologies (QRT)
98
Qube Research & Technologies (QRT)
United Kingdom
$3.68K – – –
CIG
99
Consolidated Investment Group
Colorado
– -$787K -5,000 Closed
Jane Street
100
Jane Street
New York
– -$659K -4,187 Closed
1 2 3
4
5

BBH Hedge Fund Activity: Q2 2025 in Review

98 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2025, worth a combined $115M — down 11% from $130M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of BBH and 10 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Raymond James Financial, adding an estimated $7.19M. The largest seller was Morgan Stanley, cutting an estimated $6.8M.

  • 98 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2025, down from 104 in Q1 2025.
  • Funds reported $115M of VanEck Biotech ETF stock for Q2 2025, down 11% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q2 2025 and 16 closed out, a net change of -6 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2025 was Raymond James Financial, an estimated $7.19M added.
  • The largest VanEck Biotech ETF seller in Q2 2025 was Morgan Stanley, an estimated $6.8M sold.

Based on aggregated 13F filings for Q2 2025.